bonyf
bonyf is a Swiss-manufactured public oral and dental care company selling 15 anti-biofilm, denture-care, and wound-care products across 37 countries via dental professionals, pharmacies, retail private label, and licensing partnerships.
- Company typePublic
- Founded1979
- HeadquartersVaduz, Liechtenstein
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What bonyf does
bonyf is a public Belgian-domiciled (bonyf NV) oral and dental care company founded in 1979, listed on Euronext Paris under ticker MLBON since March 2022. The company develops, manufactures, and commercializes a portfolio of 15 products across oral care (PerioTabs®, PerioCream®), denture care (OlivaFix Gold®, NitrAdine® Disinfecting Tablets, Alginate-Organic Fixative), orthodontic care, and wound/skincare (AphtoFix®, HeelFix®, FingerFix®). All products are manufactured in Switzerland under ISO 13485 conditions at bonyf Production AG, with proprietary R&D conducted in Liechtenstein's 'Dental Valley' (bonyf AG) and a corporate headquarters in Knokke-Heist, Belgium.
The company's technical foundation is the proprietary NitrAdine® anti-biofilm platform, which delivers a 5-log (99.999%) reduction against bacteria and 99.99% reduction against fungi and viruses without antibiotics or chlorhexidine. NitrAdine® is deployed across multiple SKUs and has been certified as an EU-MDR Class IIb medical device; PerioCream® holds EU-MDR Class IIa certification (September 2025). OlivaFix Gold® is positioned as the world's first healthy denture adhesive, replacing petroleum derivatives and zinc with 30% organic olive oil and delivering up to 24-hour hold. Clinical evidence includes peer-reviewed studies at University of Torino (PerioTabs®, 90% bleeding reduction), multi-center OlivaFix Gold® trials across France, Italy, and Romania (84.11% improvement), and University of Zurich collaborations.
bonyf operates a multi-channel revenue model combining branded consumer product sales through pharmacies and dental professionals, contract manufacturing and private label for major retailers (70% of 2024 sales), and licensing royalties in the US (Honest Pharma, May 2025) and India (Group Pharmaceuticals, November 2024, with 13.5% equity stake and bonyf India Ltd JV). Distribution spans 37 countries with growth concentrated in the US, India, Southeast Asia, and Japan. The company is pursuing a Nasdaq dual listing expected by end of 2026 to support further international expansion.
bonyf firmographics
Firmographics- Name
- bonyf
- Legal name
- bonyf AG
- Website
- https://bonyf.com
- Company type
- Public
- Founded year
- 1979
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- bonyf is a Swiss-manufactured public oral and dental care company selling 15 anti-biofilm, denture-care, and wound-care products across 37 countries via dental professionals, pharmacies, retail private label, and licensing partnerships.
- Ownership category
- akta.pro rank
bonyf industry classification
Industry- Product category
- Oral and Dental Care Products
- NAICS
- Dental Equipment and Supplies Manufacturing (339114), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Dental Equipment & Supplies (3843), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Denture Care (Adhesives, Cleansers, Reliners) (CRABAFAG)
- akta.pro secondary industry
- Hand & Body Care (Lotions, Creams, Body Oils) (CRADANAC)
Keywords
Where bonyf is headquartered
LocationHeadquarters
- HQ city
- Vaduz
- HQ country
- Liechtenstein
- HQ region
- Europe
Offices4 records
Markets served
bonyf business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Infrastructure
Revenue model
- Product Sales - Consumer Oral Care: Direct sales of branded oral care products including PerioTabs®, OlivaFix Gold®, and NitrAdine® tablets through pharmacies, retailers, and dental professionals. Revenue from both own-brand and private label/contract manufacturing. Private label sales grew from 37% in 2023 to 70% in 2024.
- Licensing Royalties - India: Licensing agreement with Group Pharmaceuticals for local production and distribution of NitrAdine® formulation and other bonyf products in India. Generates royalty revenue while enabling market expansion without capital investment.
- Licensing Royalties - US: Partnership with Honest Pharma for US market access with products developed in Switzerland. Honest Pharma acts as exclusive importer, with potential warrant issuance if revenue milestones are met.
- Contract Manufacturing / Private Label: Manufacturing services for retail chains and international drugstores under long-duration contracts. Leverages Swiss manufacturing facility and MDR compliance to serve private label clients. Significant growth driver in 2024.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | PerioTabs® 10-day treatment course |
Go-to-market motion3 records
Distribution channels8 records
Marketing channels9 records
bonyf product offering
Product offeringCore offering
bonyf develops, manufactures and markets oral care, denture care, orthodontic care, and wound care products under proprietary NitrAdine® anti-biofilm technology. Its portfolio spans 15 products manufactured in Switzerland, including denture adhesives (OlivaFix Gold®), periodontal treatments (PerioTabs®, PerioCream®), disinfecting tablets, mouth ulcer creams, and skincare formulations, sold through dental professionals, pharmacies, retail chains, and private label partnerships across 37 countries.
Product overview
bonyf is a Swiss premium quality company specializing in the development, production, and marketing of oral, denture, orthodontic, and wound care products. The company operates a portfolio of 15 products organized into four category groups: oral care (PerioTabs, PerioCream, NitrAdine-based treatments), denture care (OlivaFix Gold, Alginate-Organic Denture Fixative Cream, NitrAdine Disinfecting Tablets), orthodontic care, and wound/skincare (AphtoFix, HeelFix, FingerFix). The core technology platform NitrAdine powers multiple products, providing anti-biofilm disinfection and treatment capabilities. Products are manufactured in Switzerland with in-house R&D conducted in Liechtenstein. Distribution spans 37 countries with recent expansion into the U.S. and India markets.
Differentiator
Problem solved
Functional benefit
Brands
- OlivaFix Gold: World's first truly healthy denture adhesive cream containing 30% organic olive oil, zinc-free formulation providing up to 24 hours hold
- PerioTabs
- PerioCream
- NitrAdine
- AphtoFix
- HeelFix
- BonyPlus
- FingerFix
Products and services
- PerioTabs® Revolutionary brushing solution in effervescent tablet form that dissolves in water to create a treatment solution targeting oral biofilm on gums, teeth, and dental implants. Reduces gingivitis, periodontitis, peri-mucositis, and peri-implantitis without chlorhexidine. Based on NitrAdine® anti-biofilm technology. For dental professionals and consumers.
- OlivaFix Gold® World's first truly healthy denture adhesive cream containing 30% organic olive oil, zinc-free, with no petroleum derivatives or mineral oil. Provides up to 24 hours hold for upper dentures. Clinically proven superior holding time and antimycotic effect against Candida albicans. For denture wearers.
- PerioCream® Mucoadhesive periodontal paste applied by dental professionals as an adjunct to Scaling and Root Planing (SRP). Forms a protective barrier over the gum line, reduces bleeding, alleviates pain, and promotes faster healing. EU-MDR Class IIa certified medical device. For dental professionals.
- NitrAdine® Disinfecting Tablets Deep-cleaning effervescent tablet for all types of dental appliances including dentures. Provides 5-log (99.999%) disinfection against bacteria and 99.99% against fungi and viruses. Class IIb medical device under EU-MDR. For denture wearers and dental professionals.
- AphtoFix® Fast pain-relief mouth ulcer cream with muco-adhesive property that forms a protective barrier against the oral environment, promoting rapid healing. Average healing time of 7 days with significant pain reduction from day 1. For consumers with mouth ulcers.
- HeelFix® Advanced skincare formula for fast relief from heel cracks. Non-greasy, non-sticky Swiss-made formulation that provides pain relief from first application and substantial healing with continued use. For consumers with cracked skin conditions.
- FingerFix® Skincare product for finger care applications, addressing finger cracks and skin regeneration. Part of the company's advanced skincare portfolio manufactured in Switzerland.
- BonyPlus® Oral care product in the company's portfolio. Manufactured in Switzerland under ISO certified quality standards.
- Advanced Dental Bleaching & Gum Reinforcement Kit Innovative system delivering superior dental bleaching results while actively reinforcing gum health. Designed for end users/consumers seeking aesthetic dental treatments combined with gum care benefits. Showcased at IDS Cologne 2025.
- Post-Scaling Care Kit Professional dental product exclusively designed for dentists to address post-scaling challenges. Significantly reduces pain and bleeding following scaling procedures to enhance patient comfort and satisfaction. Showcased at IDS Cologne 2025.
- Contract Manufacturing / Private Label Services Contract manufacturing and private label services for retail chains and international drugstores. Leverages Swiss manufacturing facility and MDR/ISO 13485 compliance to serve private label clients with oral care products. Long-duration contracts represent a significant and growing revenue stream.
Quantifiable outcome
- 99.999% bacteria reduction (5-log reduction) with NitrAdine® technology
- +7 more outcomes
Companies that use bonyf
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles3 records
bonyf technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
bonyf partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered supporting, core and major.
- DEKRA Certification GmbHsupportingNotified body that conducted EU-MDR certification process for PerioCream Class IIa medical device. Certification confirms compliance with EU health tech regulations.
- Group PharmaceuticalscoreStrategic partnership with leading Indian oral health company. Group Pharmaceuticals acquired 13.5% stake in bonyf NV and will produce licensed bonyf products locally in India. Field force reaches over 100,000 dentists monthly. Both companies committed to co-developing new oral care solutions tailored for Indian market.
- Honest PharmacoreExclusive importer and distributor for US market. Strategic alliance to bring revolutionary oral care products to American consumers and dental professionals. Products meet FDA requirements while maintaining Swiss quality standards. Honest Pharma backed by Investment 360 with strong healthcare distribution network.
- Group Pharmaceuticals LtdcoreLicense agreement on NitrAdine® formulation for local manufacturing and distribution in India. Production planned to begin in early 2025 at Group Pharmaceuticals' cGMP-compliant facility near Mumbai. Enables large-scale manufacturing and distribution in Indian and Southeast Asian markets.
- Dental Depots (European Distributors)majorDistributors from five European countries expressing partnership intent for PerioCream rollout. Dental Depots serve as key distribution channel for professional dental products across Europe.
- University of ZurichsupportingAcademic research partner evaluating prophylactic and therapeutic efficacy of PerioTabs® through clinical studies. Published preliminary research in Applied Sciences journal.
- CIR-Dental School, University of TorinosupportingClinical research partner conducting gingivitis study in collaboration with periodontologists at Studio Sicor (Torino). Study published in European Journal of Dentistry demonstrating PerioTabs® efficacy.
Scale indicators10 records
Recent moves8 records
Expansion highlights6 records
bonyf competitors and assessment
Company assessmentDirect peers
- Haleon: Spun out of GSK in 2022, Haleon owns leading denture adhesive brands Polident and Poligrip as well as Sensodyne toothpaste. It is the closest direct peer in denture adhesives and adjacent oral care, competing with bonyf's OlivaFix Gold and NitrAdine tablets across retail pharmacy channels.
- Dentaid: Spanish oral care specialist (Vitis, Interprox, Desensin) focused on dental professional channels and pharmacy retail in Europe and Latin America. Comparable in product range (toothpaste, mouthwash, interdental), channel mix, and European market positioning.
- Sunstar: Swiss-headquartered oral care specialist behind the GUM brand, with deep focus on periodontal and interdental products. Highly comparable to bonyf in clinical positioning, dental professional channel, and category focus on gum disease prevention.
Regional players
- Dermapharm: German specialty pharma group with branded dermatology and consumer health products including select oral care adjacencies. Comparable as a small/mid-cap European specialty pharma pursuing branded consumer healthcare via retail and pharmacy channels.
Emerging players
- Pierrel: Italian-listed dental pharmaceutical company specializing in oral care and dental anesthesia products. Comparable to bonyf as a smaller public dental-specialty player pursuing international expansion and dental professional channel sales.
Broad incumbents
- Church & Dwight: US-listed CPG company with oral care offerings (Orajel, Batiste-adjacent personal care). Competes against bonyf's AphtoFix mouth ulcer cream and broader oral care portfolio via pharmacy retail distribution.
- Dentsply Sirona: Largest global dental equipment and consumables manufacturer. Overlaps with bonyf's professional dental channel focus and serves periodontists and dental specialists with overlapping clinical audiences, though at vastly greater scale and with broader equipment offerings.
- Colgate-Palmolive: Global oral care leader via Colgate, elmex, meridol, and other brands. Competes with bonyf in consumer oral care and denture products across the same retail and dental professional channels.
- Procter & Gamble: Owns the Fixodent denture adhesive brand and Crest oral care line. P&G is a broad CPG incumbent with massive R&D and marketing budgets and global retail reach, competing against bonyf in denture fixation and oral hygiene.
- Pierre Fabre: French pharmaceutical and dermo-cosmetic group with an oral care portfolio (Elgydium, Arthrodont) sold primarily through dental professionals and pharmacies in Europe. Overlaps with bonyf's professional channel focus and European pharmacy distribution.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
bonyf social profiles
Digital presencebonyf compliance and trust
Trust signalCompliance7 records
bonyf financial estimates
Financial estimateRevenue estimate
Valuation estimate
bonyf leadership team
Management profileNumber of profiles
Profiles3 records
bonyf subsidiaries and ownership
Company hierarchySubsidiaries3 records
bonyf funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
bonyf M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about bonyf
What does bonyf do?
bonyf develops, manufactures and markets oral care, denture care, orthodontic care, and wound care products under proprietary NitrAdine® anti-biofilm technology. Its portfolio spans 15 products manufactured in Switzerland, including denture adhesives (OlivaFix Gold®), periodontal treatments (PerioTabs®, PerioCream®), disinfecting tablets, mouth ulcer creams, and skincare formulations, sold through dental professionals, pharmacies, retail chains, and private label partnerships across 37 countries.
Is bonyf a public or private company?
bonyf is a public company. It is classified as public and is currently operating.
When was bonyf founded?
bonyf was founded in 1979. It employs 11 to 50 people.
Where is bonyf based?
bonyf is headquartered in Vaduz, Liechtenstein, in the Europe region.
How does bonyf make money?
Four revenue lines are on record. Product Sales - Consumer Oral Care is the primary driver. The others are licensing Royalties - India, licensing Royalties - US and contract Manufacturing / Private Label.
Who are bonyf's main competitors?
Direct peers on record are Haleon, Dentaid and Sunstar. Dermapharm is listed as a regional player. Pierrel is listed as an emerging player. Broad incumbents are Church & Dwight, Dentsply Sirona, Colgate-Palmolive, Procter & Gamble and Pierre Fabre.
Does bonyf have an API?
No public API is recorded for bonyf.
What industry is bonyf in?
bonyf's product category is Oral and Dental Care Products. Its primary akta.pro industry code is CRABAFAG, Denture Care (Adhesives, Cleansers, Reliners), with a secondary code of CRADANAC, Hand & Body Care (Lotions, Creams, Body Oils). Its NAICS code is 339114 and its SIC code is 3843.